Author's reply

Day, C.P.
December 2002
Gut;Dec2002, Vol. 51 Issue 6, p898
Academic Journal
Replies to a comment on an article on the pathogenesis and clinical relevance of non-alcoholic steatohepatitis (NASH) published in 'Gut' in 2002. Use of liver biopsy in patients with suspected NASH.


Related Articles

  • Detection assessment and monitoring of hepatic fibrosis: biochemistry or biopsy? Mardini, H; Record, C // Annals of Clinical Biochemistry;Nov2005, Vol. 42 Issue 6, p441 

    Hepatic fibrosis is an important consequence of inflammatory disorders affecting the liver, and ultimately progresses to cirrhosis. Here we explore methods for the detection and monitoring of hepatic fibrosis, particularly in hepatitis C, alcoholic liver disease, non-alcoholic fatty liver...

  • Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Arena, U.; Vizzutti, F.; Abraldes, J. G.; Corti, G.; Stasi, C.; Moscarella1, S.; Milani, S.; Lorefice, E.; Petrarca, A.; Romanelli, R. G.; Laffi, G.; Bosch, J.; Marra, F.; Pinzani, M. // Gut;Sep2008, Vol. 57 Issue 9, p1288 

    Background: Transient elastography (TE) has received increasing attention as a means to evaluate disease progression in patients with chronic liver disease. Aim: To assess the value of TE for predicting the stage of fibrosis. Methods: Liver biopsy and TE were performed in 150 consecutive...

  • Possible Hepatotoxicity of Doxidan. Tolman, Keith G.; Hammar, Samuel; Sannella, Jospeh J. // Annals of Internal Medicine;Mar76, Vol. 84 Issue 3, p290 

    Deals with a patient who developed leukopenia and liver disease while taking the laxative Doxidan. Information on the liver biopsy taken during the active phase of hepatitis; Association of chronic aggressive hepatitis and leukopenia with ingestion of Doxidan.

  • Sulfasalazine Hepatotoxicity. Fich, A.; Schwartz, J.; Braverman, D.; Zifroni, A.; Rachmilewitz, D. // American Journal of Gastroenterology;May1984, Vol. 79 Issue 5, p401 

    Hepatotoxicity has been recently described as a rare complication of sulfasalazine therapy. Two patients with hepatic damage after sulfasalazine treatment are reported. Liver biopsy performed in one patient revealed granulomatous hepatitis. On rechallenge with 5 aminosalicylic acid enema the...

  • Nonalcoholic Steatohepatitis and the "Bright Liver Syndrome": Should a Recently Expanded Clinical Entity be Further Expanded? Lonardo, Amedeo; Bellini, Massimo; Tondelli, Emilio; Frazzoni, Marzio; Grisendi, Alberto; Pulvirenti, Maurizio; Casa, Giovanni Della // American Journal of Gastroenterology;Nov1995, Vol. 90 Issue 11, p2072 

    Provides information on a study that investigated nonalcoholic steatohepatitis which is a clinicopathological entity in which macrovescicolar steatosis and parenchymal inflammation are shown by liver biopsy specimens in the absence of a history of excessive ethanol ingestion. Methodology of the...

  • Hepascore predictive of mortality, morbidity in chronic HCV.  // Infectious Disease News;Sep2013, Vol. 26 Issue 9, p28 

    The article focuses on the accuracy of Hepascore, a noninvasive measurement of liver fibrosis, that can be compared to that of liver biopsy in predicting mortality and liver-related morbidity on patients with chronic hepatitis C, which was revealed by a research that covered 406 patients with...

  • CHARACTERISATION OF DIFFUSE LIVER DISEASE IN PATIENTS WITH HEPATITIS C USING [sup 31]P MAGNETIC RESONANCE SPECTROSCOPY (MRS). Lim, A.K.P.; Patel, N.; Hamilton, G.; Hajnal, J.V.; Goldin, R.; Taylor-Robinson, S.D. // Gut;Apr2003 Supplement 1, Vol. 52, pA3 

    Purpose: Liver biopsy remains the gold standard for characterising and staging diffuse liver disease. This invasive test is associated with significant morbidity and, rarely, mortality. Our aim was to investigate whether a non-invasive technique, in vivo [sup 31]P-(MRS) could grade the severity...

  • HEPATIC GRANULOMAS: A 10 YEAR SINGLE CENTRE EXPERIENCE. Gaya, D.R.; Thorburn, D.; Oien, K.A.; Morris, A.J.; Stanley, A.J. // Gut;Apr2003 Supplement 1, Vol. 52, pA104 

    Introduction: Epitheliod granulomas have been reported in 2-15% of unselected liver biopsies with numerous underlying aetiologies described. However, most series were reported prior to the identification of hepatitis C and the improvement in laboratory markers of other causes of liver...

  • Esteatohepatitis no alcohólica. López, Erika Martínez; Rosales, José Alfredo Domínguez; Nazara, Zamira Helena Hernández; Cerda, Arturo Panduro // Investigación en Salud;mar2005 Special, Issue 7, p40 

    In 1980, Ludwing and colleagues described patients who lacked a history of alcohol consumption but had findings on liver biopsy that could not be distinguished from those patients with alcoholic hepatitis. Since then, "nonalcoholic steatohepatitis" (NASH) was coined. Diagnostic criteria for NASH...


Read the Article


Sign out of this library

Other Topics